Moneycontrol PRO
HomeNewsBusinessTorrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct

Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct

Net Sales are expected to increase by 11 percent Y-o-Y (up 11.1 percent Q-o-Q) to Rs 2,367.8 crore, according to ICICI Direct.

July 13, 2022 / 19:35 IST
Torrent Pharma | The scrip added over 10 percent after the board recommended issue of bonus shares in the ratio of 1:1 or one share for each fully paid up share held. The company has also declared a final dividend of Rs 23 (460 percent) per share of Rs 5 each including special dividend of Rs 15 per share. Torrent swung to a net loss of Rs 118 crore for the fourth quarter ended March 31 as headwinds buffeted its EU business and the liquids business discontinued in the US. The company had registered a profit after tax of Rs 324 crore in the corresponding quarter of last year.

Torrent Pharma | The scrip added over 10 percent after the board recommended issue of bonus shares in the ratio of 1:1 or one share for each fully paid up share held. The company has also declared a final dividend of Rs 23 (460 percent) per share of Rs 5 each including special dividend of Rs 15 per share. Torrent swung to a net loss of Rs 118 crore for the fourth quarter ended March 31 as headwinds buffeted its EU business and the liquids business discontinued in the US. The company had registered a profit after tax of Rs 324 crore in the corresponding quarter of last year.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

ICICI Direct has come out with its first quarter (April-June’ 22) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Torrent Pharma to report net profit at Rs 339.1 crore up 2.8% year-on-year (down 37.2% quarter-on-quarter).

Net Sales are expected to increase by 11 percent Y-o-Y (up 11.1 percent Q-o-Q) to Rs 2,367.8 crore, according to ICICI Direct.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 2.1 percent Y-o-Y (up 18.2 percent Q-o-Q) to Rs 663 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

ICICI_Pharma

Broker Research
first published: Jul 13, 2022 07:35 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347